# KCNJ9

## Overview
The KCNJ9 gene encodes the protein potassium inwardly rectifying channel subfamily J member 9, commonly referred to as GIRK3. This protein is a subunit of G-protein-coupled inwardly rectifying potassium channels, which are integral membrane proteins that play a critical role in regulating potassium ion flow across the cell membrane. These channels are essential for maintaining the resting membrane potential and modulating neuronal excitability. GIRK3, in particular, is predominantly expressed in the brain, where it forms tetrameric complexes with other GIRK subunits, such as GIRK2, to facilitate proper channel function. The structural integrity and function of GIRK3 are influenced by specific residues, such as Phe326, which are crucial for maintaining hydrophobic interactions within the protein. Mutations in KCNJ9, such as the Phe326Ser variant, have been associated with neurological conditions, highlighting the gene's importance in neuronal signaling and its potential as a therapeutic target (Kochetkova2023De; Kozell2009Mapping).

## Structure
The KCNJ9 gene encodes the GIRK3 protein, a subunit of G-protein-coupled inwardly rectifying potassium channels. These channels typically form tetrameric structures, with each subunit contributing to the central pore. The primary structure of GIRK3 includes two transmembrane domains, M1 and M2, and a pore-forming region known as H5 (Kochetkova2023De). The secondary structure features alpha-helices and beta-sheets, which are arranged in the tertiary structure to form the functional channel. 

The Phe326 residue in the KCNJ9 protein is located in the cytoplasmic domain of GIRK3 and is involved in forming hydrophobic contacts with the valine side chain and aliphatic carbons of the arginine side chain. A de novo missense variant, p.Phe326Ser, has been identified, which is predicted to disrupt these interactions, potentially affecting the protein's stability and function (Kochetkova2023De). 

The quaternary structure involves the formation of GIRK2/GIRK3 tetramers, which are essential for proper channel function. The Phe326Ser mutation may destabilize these tetramers, impacting the channel's activity (Kochetkova2023De). The protein's structure was modeled using techniques like AlphaFold and HHpred/Modeller, based on homologous structures (Kochetkova2023De).

## Function
The KCNJ9 gene encodes a G-protein-coupled inwardly rectifying potassium (K+) channel subunit known as GIRK3. This protein is part of a family of potassium channels that regulate the flow of potassium ions across the cell membrane, which is crucial for maintaining the cell's resting membrane potential and modulating electrical signaling in neurons (Kochetkova2023De). In healthy human cells, KCNJ9 is primarily active in the brain, where it influences neuronal signaling and potentially affects processes such as neurotransmitter release and synaptic plasticity. The protein forms part of GIRK2/GIRK3 tetramers, which are necessary for proper channel function (Kochetkova2023De).

The Phe326 residue in the KCNJ9 protein is conserved among different species, suggesting an important structural or functional role. Computational modeling has shown that this residue forms hydrophobic contacts with other residues, which are crucial for maintaining the protein's structure. Disruption of these contacts, such as through a Phe326Ser mutation, may affect the protein's function, although the exact consequences in healthy human cells are not fully elucidated (Kochetkova2023De).

## Clinical Significance
Mutations and alterations in the expression of the KCNJ9 gene, which encodes the GIRK3 subunit, have been implicated in various neurological conditions. A study identified a de novo heterozygous missense mutation in KCNJ9 as a potential cause of neonatal seizures. This mutation, which was not found in control samples, is considered likely pathogenic and may disrupt hydrophobic interactions in the protein's cytoplasmic domain, potentially destabilizing the structure necessary for proper function (Kochetkova2023De).

In the context of substance withdrawal, KCNJ9 has been associated with withdrawal symptoms from sedative-hypnotics such as pentobarbital, zolpidem, and ethanol. Kcnj9-null mutant mice exhibit reduced withdrawal symptoms compared to wild-type mice, suggesting that the gene plays a role in modulating withdrawal severity. This is thought to be due to increased GIRK-GABA B receptor coupling efficiency in certain brain regions, which influences withdrawal severity (Kozell2009Mapping).

The gene's involvement in these conditions highlights its significance in regulating neuronal excitability and its potential as a target for therapeutic interventions in related disorders. Further research is needed to fully understand the mechanisms by which KCNJ9 mutations and expression alterations contribute to these clinical outcomes.

## Interactions



## References


[1. (Kochetkova2023De) Taisiya O. Kochetkova, Dmitry N. Maslennikov, Ekaterina R. Tolmacheva, Jekaterina Shubina, Anna S. Bolshakova, Dzhenneta I. Suvorova, Anna V. Degtyareva, Irina V. Orlovskaya, Maria V. Kuznetsova, Anastasia A. Rachkova, Gennady T. Sukhikh, Denis V. Rebrikov, and Dmitriy Yu. Trofimov. De novo variant in the kcnj9 gene as a possible cause of neonatal seizures. Genes, 14(2):366, January 2023. URL: http://dx.doi.org/10.3390/genes14020366, doi:10.3390/genes14020366. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes14020366)

[2. (Kozell2009Mapping) Laura B. Kozell, Nicole A. R. Walter, Lauren C. Milner, Kevin Wickman, and Kari J. Buck. Mapping a barbiturate withdrawal locus to a 0.44 mb interval and analysis of a novel null mutant identify a role forkcnj9(girk3) in withdrawal from pentobarbital, zolpidem, and ethanol. The Journal of Neuroscience, 29(37):11662â€“11673, September 2009. URL: http://dx.doi.org/10.1523/JNEUROSCI.1413-09.2009, doi:10.1523/jneurosci.1413-09.2009. This article has 72 citations.](https://doi.org/10.1523/JNEUROSCI.1413-09.2009)